Susan E. Moody - Concepedia

Concepedia

Author

Susan E. Moody

University of Pennsylvania ORCID

Also Known As

Moody, Susan Elizabeth, S E Moody, S Moody, S. E. Moody, Susan E Moody, Susan E. Moody, Susan Elizabeth Moody, Susan Moody

114

Publications

8.5K

Citations

28

H-Index

59

Concepts

All Affiliations

University of Pennsylvania Dana-Farber Cancer Institute Novartis (Switzerland)Cancer Research Institute Harvard University

SE

About

Susan E. Moody is an author at University of Pennsylvania specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	7K
2	Cell Biology	13	13	6.6K
3	Engineering	2	2	114
4	Health Sciences	2	2	53
5	Biomedical Engineering	1	1	31

Susan E. Moody

×

36

Publications

8.5K

Citations

28

H-Index

	Year	Citations
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 David A. Barbie, Pablo Tamayo, Jesse S. Boehm, Nature Systems BiologyOncogenic AgentMedicineKras-driven CancersCancer Biology	2009	4.1K
The transcriptional repressor Snail promotes mammary tumor recurrence Susan E. Moody, Denise Perez, Tien-Chi Pan, Cancer Cell Transcriptional RegulationTranscriptional Repressor SnailMammary GlandMedicineCell Biology	2005	723
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis Christopher J. Sarkisian, Blaine A. Keister, Douglas B. Stairs, Nature Cell Biology Breast OncologyOncologyOncogenic AgentMedicineCellular Senescence	2007	486
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations Celina M. D’Cruz, Edward J. Gunther, Robert Boxer, Nature Medicine Spontaneous Kras2 MutationsPreferred PathwayCell RegulationMammary GlandBreast Cancer	2001	417
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis Susan E. Moody, Christopher J. Sarkisian, Kristina Hähn, Cancer Cell Tumor BiologyMammary EpitheliumOncogenic AgentMedicineImmunology	2002	349
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis Edward J. Gunther, Susan E. Moody, George K. Belka, Genes & Development	2003	208
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors Leila Dardaei, Hui Qin Wang, Manrose Singh, Nature Medicine Alk InhibitorsMedicinePharmacologyBronchial NeoplasmImmune Checkpoint Inhibitor	2018	198
Inhibition of <i>KRAS</i> -Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit Zehua Zhu, Amir Reza Aref, Travis J. Cohoon, Cancer Discovery	2014	190
Persistent Parity-Induced Changes in Growth Factors, TGF-β3, and Differentiation in the Rodent Mammary Gland Celina M. D’Cruz, Susan E. Moody, Stephen R. Master, Molecular Endocrinology	2002	165
Conditional Overexpression of Active Transforming Growth Factor β1 <b> <i>In vivo</i> </b> Accelerates Metastases of Transgenic Mammary Tumors Rebecca S. Muraoka-Cook, Hirokazu Kurokawa, Yasuhiro Koh, Cancer Research	2004	159

Page 1